Danaher Corporation $DHR Shares Sold by First Manhattan CO. LLC.

Posted by on Jun 18th, 2026

First Manhattan CO. LLC. lowered its position in Danaher Corporation (NYSE:DHR – Free Report) by 0.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,309,711 shares of the conglomerate’s stock after selling 6,166 shares during the quarter. Danaher makes up 1.4% of First Manhattan CO. LLC.’s investment portfolio, making the stock its 12th biggest position. First Manhattan CO. LLC.’s holdings in Danaher were worth $529,414,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. State Street Corp raised its stake in shares of Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after purchasing an additional 472,608 shares in the last quarter. Capital International Investors raised its stake in shares of Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after purchasing an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Danaher by 9.1% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after purchasing an additional 1,334,221 shares in the last quarter. Norges Bank acquired a new stake in shares of Danaher in the 4th quarter valued at about $2,177,106,000. Finally, Generation Investment Management LLP raised its stake in shares of Danaher by 14.1% in the 4th quarter. Generation Investment Management LLP now owns 7,589,661 shares of the conglomerate’s stock valued at $1,737,425,000 after purchasing an additional 934,995 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

DHR opened at $177.85 on Thursday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The firm has a market cap of $125.88 billion, a price-to-earnings ratio of 34.40, a price-to-earnings-growth ratio of 2.31 and a beta of 0.81. The company’s 50-day moving average price is $180.26 and its 200 day moving average price is $203.59.

Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the prior year, the firm earned $1.88 EPS. Danaher’s quarterly revenue was up 3.7% on a year-over-year basis. As a group, sell-side analysts expect that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on DHR shares. Robert W. Baird dropped their price objective on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research note on Friday, April 17th. Piper Sandler started coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective on the stock. TD Cowen dropped their price objective on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. DZ Bank started coverage on shares of Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective on the stock. Finally, Wells Fargo & Company dropped their price objective on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $233.61.

View Our Latest Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.